Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Phenothrin→

Phenothrin Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
26002-80-2
Molecular formula
C23H26O3
Molecular weight
350.4 g/mol
Drug class
Synthetic pyrethroid ectoparasiticidepediculicide
Mechanism of action
Acts on voltage-gated sodium channels in arthropod nerve membranes, prolonging channel opening and disrupting nerve repolarisation. This causes paralysis and death of susceptible lice and other ectoparasites.
Indications / reported uses
  • Topical treatment of head lice and other susceptible ectoparasite infestations in jurisdictions where phenothrin-containing products are authorised.

Sources: https://www.ncbi.nlm.nih.gov/mesh/?term=phenothrin · https://pubchem.ncbi.nlm.nih.gov/#query=phenothrin · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Phenothrin Environmental Risk Assessment (ERA) (the Phenothrin ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.